RESUMEN
PURPOSE: The purpose of this study was (a) to suggest a novel dermatopharmacokinetic (DPK) approach from which pharmacokinetic parameters relevant to the bioequivalence (BE) assessment of a topical formulation can be deduced while circumventing the need for numerous measurements and assumptions, and (b) to investigate whether this approach enables the correct conclusion of BE and bioinequivalence (BIE). METHODS: Bioequivalent and bioinequivalent formulations of acyclovir were compared versus a reference product (Zovirax®). Tape Stripping was conducted at only one dose duration during the uptake phase to generate drug content in stratum corneum versus time profiles, each time point corresponding to one stripped layer. Nonlinear mixed effect modeling (ADAPT5®) (MLEM algorithm) was used to fit the DPK data and to estimate the rate (Kin) and extent (FS) of drug absorption/input into the skin. Results were evaluated using the average BE approach. RESULTS: Estimated exposure metrics were within the usual BE limits for the bioequivalent formulation (FS: 102.4 [90%CI: 97.5-107.7]; Kin: 94.2 [90%CI: 83.7-106.0]), but outside those limits for the bioinequivalent formulation (FS: 43.4 [90%CI: 27.9-67.6]; Kin: 54.5 [90%CI: 36.6-81.1]). CONCLUSIONS: The proposed novel DPK approach was shown to be successful, robust and applicable to assess BE and BIE correctly between topical formulations.
Asunto(s)
Pomadas/química , Administración Cutánea , Disponibilidad Biológica , Química Farmacéutica/métodos , Epidermis/efectos de los fármacos , Femenino , Humanos , Masculino , Pomadas/farmacocinética , Pomadas/farmacología , Piel/efectos de los fármacos , Absorción Cutánea/fisiología , Equivalencia TerapéuticaRESUMEN
Direct comparisons between skin absorption data and clinical pharmacokinetic data are rare. Here we use the lipophilic nonsteroidal selective glucocorticoid receptor agonist BAY1003803 to make such a comparison. The objective is to find the extent to which measurements of skin permeation in vitro can be used to predict the corresponding permeation in vivo for human pharmacokinetics of topically applied substances. BAY1003803 was prepared in various formulations: ointment, hydrophilic cream, lipophilic cream, and milk. Its ability to permeate healthy human skin was measured in vitro in static diffusion cells, and percutaneous absorption as well as dermal delivery was measured thereafter, for 2 selected formulations, in vivo in healthy volunteers. Absorption in vivo comparing ointment and lipophilic cream was correlated with expectation based on the dermal delivery obtained in vitro. A 2.17-fold higher systemic exposure to BAY1003803 was achieved by the ointment formulation. This is well in line with the predicted exposure difference of 2.74 based on the in vitro data. In conclusion, in vitro skin absorption studies using human skin are suitable for the prediction of systemic exposure and formulation effects in vivo; they can therefore be applied to guide the design of clinical investigations of dermatological preparations.
Asunto(s)
Pomadas/farmacocinética , Receptores de Glucocorticoides/agonistas , Absorción Cutánea/fisiología , Crema para la Piel/farmacocinética , Piel/efectos de los fármacos , Administración Tópica , Adulto , Cromatografía/métodos , Método Doble Ciego , Composición de Medicamentos/métodos , Diseño de Fármacos , Humanos , Masculino , Persona de Mediana Edad , Pomadas/metabolismo , Valor Predictivo de las Pruebas , Receptores de Glucocorticoides/metabolismo , Piel/metabolismo , Crema para la Piel/metabolismoRESUMEN
To establish a determination method for the contents of ammonium glycyrrhetate,nardosinone,and curcumin in transdermal receptor liquid of Baimai Ointment,and investigate the percutaneous permeability of Baimai Ointment and the effects of two kinds of penetration enhancers on percutaneous absorption of three components. The contents of ammonium glycyrrhetate,nardosinone,and curcumin in transdermal receptor liquid were determined by high pressure liquid chromatography( HPLC). The vertical modified Franz diffusion cell was used to perform a transdermal experiment in vitro with the abdominal skin of mice( treated and untreated). The transdermal receptor liquid was preferably used to investigate the transdermal absorption rule of the Baimai Ointment and the effect of the penetration enhancer. The results showed that the comprehensive solubility of PEG-ET-NS( 3 â¶3 â¶4) was best among three types of receptor liquid PG-ET-NS( 3 â¶3 â¶4),PEG-ET-NS( 3 â¶3 â¶4),ET-NS( 3 â¶7). PEG-ET-NS was used as the receptor liquid for in vitro transdermal experiments. The cumulative permeation area of ammonium glycyrrhetate,nardosinone and curcumin within 24 h was 5. 73,18. 99,0. 38 µg·cm~(-2)respectively. Taking QEFand ER as comprehensive evaluation indicators of permeation performance,the comprehensive penetration-promoting performance of ammonium glycyrrhizinate: 3% PEG 400-ethanol-normal saline ≈ 1. 19 times( 3%azone) = 1. 94 times( blank); comprehensive penetration-promoting performance of nardosinone: 3% PEG 400-ethanol-normal saline≈1. 28 times( 3% azone) = 1. 37 times( blank); the comprehensive penetration performance of curcumin: 3% PEG 400-ethanol-normal saline≈1. 77 times( 3% azone) ≈3. 42 times( blank). The comprehensive penetration enhancement properties of the two penetration enhancers were as follows: 3% PEG 400-ethanol-normal saline>3%azone>blank. The transdermal absorption curve of ammonium glycyrrhetate,nardosinone and curcumin in Baimai Ointment were consistent with the zero-order equation,indicating that the transdermal absorption process was irrelevant to the concentration of three components,and its was a diffusion process. This experiment provides reference for the study of ointment transdermal preparations.
Asunto(s)
Administración Cutánea , Pomadas/farmacocinética , Absorción Cutánea , Piel , Animales , Ratones , PermeabilidadRESUMEN
Topical application of Vitamin K1 has been demonstrated to effectively treat papulopustular skin rash, a serious and frequently encountered side effect of Epidermal Growth Factor Inhibitors (EGFRIs). Systemic absorption of vitamin K1 from skin and the resultant consequence of antagonizing EGFRIs anticancer effects jeopardizes the clinical acceptability of this rather effective treatment. The purpose of the present study was to rationally formulate and evaluate the release rate and transdermal absorption of a wide range of Vitamin K1 dermal preparations with a variety of physiochemical properties. A library of 33 formulations with were compounded and tested for Vitamin K1 permeation using hydrophobic membranes and porcine skin mounted in a Fran diffusion cells. Our results demonstrate the lowest diffusion for water-in-oil emulsions, which also demonstrated a negligible transdermal absorption. The statistical analysis showed a significant correlation between in vitro and ex vivo results. While viscosity did not have a significant impact on the diffusion or absorption of vitamin K1, an increase in the lipid content was correlated with an increase in transmembrane diffusion (not with transdermal absorption). Overall, formulation design significantly impacts the release rate and transdermal absorption of vitamin K1, and confirms the possibility of minimal systemic distribution of this vitamin for this specific purpose.
Asunto(s)
Fármacos Dermatológicos/administración & dosificación , Fármacos Dermatológicos/farmacocinética , Absorción Cutánea/efectos de los fármacos , Enfermedades de la Piel/tratamiento farmacológico , Vitamina K 1/administración & dosificación , Vitamina K 1/farmacocinética , Administración Tópica , Animales , Antineoplásicos/efectos adversos , Fármacos Dermatológicos/metabolismo , Difusión , Emulsiones/administración & dosificación , Emulsiones/química , Emulsiones/farmacocinética , Geles/administración & dosificación , Geles/química , Geles/farmacocinética , Técnicas In Vitro , Lípidos/química , Membranas Artificiales , Pomadas/administración & dosificación , Pomadas/química , Pomadas/farmacocinética , Piel/efectos de los fármacos , Piel/metabolismo , Crema para la Piel/administración & dosificación , Crema para la Piel/química , Crema para la Piel/farmacocinética , Enfermedades de la Piel/inducido químicamente , Tensoactivos/química , Sus scrofa , Viscosidad , Vitamina K 1/metabolismo , Agua/químicaRESUMEN
BACKGROUND: The aim of this paper is to evaluate a simple in vitro skin penetration experiment in which the drug is extracted from the whole skin piece as a test valid for formulation screening and optimization during development process, equivalence assessment during quality control or postapproval after changes to the product. METHODS: Twelve clobetasol propionate (CP) formulations (six creams and six ointments, being five generics and one reference from each formulation type) from the local market were used as a model to challenge the evaluated methodology in comparison to in vitro skin penetration following tape-stripping for drug extraction. To support the results, physicochemical tests for pH, viscosity, density and assay, as well as in vitro release were performed. RESULTS: Both protocols, extracting the drug from the skin using the tape-stripping technique or extracting from the full skin were capable of differentiating CP formulations. Only one formulation did not present statistical difference from the reference drug product in penetration tests and only other two oitments presented equivalent release to the reference. The protocol is straightforward and reproducible. CONCLUSION: Results suggest the bioinequavalence of tested CP formulations reinforcing the necessity of such evaluations.
Asunto(s)
Clobetasol/farmacocinética , Medicamentos Genéricos/farmacocinética , Glucocorticoides/farmacocinética , Pomadas/farmacocinética , Crema para la Piel/farmacocinética , Piel/metabolismo , Administración Tópica , Animales , Química Farmacéutica , Liberación de Fármacos , Concentración de Iones de Hidrógeno , Absorción Cutánea , Solubilidad , Porcinos , Equivalencia Terapéutica , ViscosidadRESUMEN
BACKGROUND: Rat skin and goat cul de sac are mostly used in optimization of formulations as the model of human skin and cul de sac. AIM: To explore the correlation between lipid content of rat skin and goat cul de sac and permeability. MATERIALS AND METHODS: Find out wavelength maximum for Sapat plus malam®, Ciplox eye ointment® and chloramphenicol eye caps and the standard curve was also derived. In vitro studies using Cellophane® membrane and ex vivo studies using rat skin or goat cul de sac of the formulations. Permeability coefficient, % dislodgeable dose, lag time, diffusion parameter, and partition coefficient were found for both studies after six and a half hours of penetration studies. Student's unpaired t-test with equal variance was used to find any statistically significant difference in the ex vivo and in vitro diffusion transport studies at 95% level of confidence. RESULTS: Permeability coefficient of Sapat plus malam®, Ciplox eye ointment® and chloramphenicol eye caps were 0.000316 ± 0.0000625, 0.00416 ± 0.0001, 0.0034 ± 0.00004 for Cellophane® membrane and 0.0001 ± 0.000001, 0.002254 ± 0.0002, 0.00303 ± 0.0001 for ex vivo membrane in cm2/min, respectively. For all three formulations, there were calculated t values which were higher than tabulated t values at 95% of confidence level (P<0.05). CONCLUSION: Cellophane® membrane shows a better diffusion than rat skin or goat cul de sac. In the optimization of formulation, only Cellophane® membrane is advisable to use.
Asunto(s)
Cloranfenicol/farmacocinética , Pomadas/farmacocinética , Absorción Cutánea/efectos de los fármacos , Administración Oftálmica , Animales , Cabras , Técnicas In Vitro , India , Lípidos/análisis , Membranas/efectos de los fármacos , Permeabilidad/efectos de los fármacos , Ratas , Sensibilidad y EspecificidadRESUMEN
Various strategies for ocular drug delivery are considered; from basic formulation techniques for improving availability of drugs; viscosity enhancers and mucoadhesives aid drug retention and penetration enhancers promote drug transport into the eye. The use of drug-loaded contact lenses and ocular inserts allows drugs to be better placed where they are needed for more direct delivery. Developments in ocular implants gives a means to overcome the physical barriers that traditionally prevented effective treatment. Implant technologies are under development allowing long-term drug delivery from a single procedure, these devices allow posterior chamber diseases to be effectively treated. Future developments could bring artificial corneas to eliminate the need for donor tissue and one-off implantable drug depots lasting the patient's lifetime.
Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Oftalmopatías/tratamiento farmacológico , Pomadas/administración & dosificación , Soluciones Oftálmicas/administración & dosificación , Implantes Absorbibles , Disponibilidad Biológica , Lentes de Contacto , Humanos , Inyecciones Intravítreas , Nanopartículas/química , Pomadas/química , Pomadas/farmacocinética , Soluciones Oftálmicas/química , Soluciones Oftálmicas/farmacocinética , Solubilidad , Adhesivos Tisulares/química , ViscosidadRESUMEN
The paeonol proniosomes ointment and ordinary ointment were administered to rats. Physiological saline served as perfused solution. The perfusion rate was 5 mL x L(-1) and the microdialysis samples were collected every 20 min intervals. The paeonol concentration in perfused solution was determined by HPLC. Investigation of the pharmacokinetics of paeonol proniosomes ointment and ordinary ointment by the skin-blood synchronous microdialysis coupled with HPLC is reported in this study. The results show that the recovery was (54.80 +/- 1.50)% in vitro and (54.58 +/- 4.61)% in vivo. The results showed that paeonol proniosomes ointment significantly raised the drug concentrations in skin more than the paeonol ordinary ointment. The paeono proniosomes ointment has less drugs into the blood as the ordinary ointments in blood, but its blood drug concentrations were steadier. The paeonol proniosomes ointment may be developed into a new preparation.
Asunto(s)
Acetofenonas/farmacocinética , Sistemas de Liberación de Medicamentos/métodos , Medicamentos Herbarios Chinos/farmacocinética , Paeonia/química , Acetofenonas/administración & dosificación , Acetofenonas/sangre , Acetofenonas/química , Animales , Sistemas de Liberación de Medicamentos/instrumentación , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/química , Masculino , Microdiálisis , Pomadas/administración & dosificación , Pomadas/química , Pomadas/farmacocinética , Ratas , Ratas Wistar , Piel/metabolismoRESUMEN
A novel nanoscale-dispersed eye ointment (NDEO) for the treatment of severe evaporative dry eye has been successfully developed. The excipients used as semisolid lipids were petrolatum and lanolin, as used in conventional eye ointment, which were coupled with medium-chain triglycerides (MCT) as a liquid lipid; both phases were then dispersed in polyvinyl pyrrolidone solution to form a nanodispersion. Single-factor experiments were conducted to optimize the formulations. A transmission electron micrograph showed that the ointment matrix was entrapped in the nanoemulsion of MCT, with a mean particle size of about 100 nm. The optimized formulation of NDEO was stable when stored for six months at 4 °C, and demonstrated no cytotoxicity to human corneal epithelial cells when compared with commercial polymer-based artificial tears (Tears Natural Forte). The therapeutic effects of NDEO were evaluated on a mouse model with 'dry eye'. Both the tear break-up time and fluorescein staining demonstrated therapeutic improvement, displaying a trend of positive correlation with higher concentrations of ointment matrix in the NDEO formulations compared to a marketed product. Histological evaluation demonstrated that the NDEO restored the normal corneal and conjunctival morphology and is safe for ophthalmic application.
Asunto(s)
Síndromes de Ojo Seco/tratamiento farmacológico , Pomadas/administración & dosificación , Pomadas/farmacocinética , Soluciones Oftálmicas/efectos adversos , Soluciones Oftálmicas/farmacocinética , Animales , Modelos Animales de Enfermedad , Emulsiones/farmacología , Células Epiteliales/efectos de los fármacos , Fluoresceína/farmacología , Humanos , Lanolina/administración & dosificación , Ratones , Ratones Endogámicos BALB C , Microscopía Electrónica de Transmisión , Nanopartículas/efectos adversos , Vaselina/administración & dosificación , Triglicéridos/administración & dosificaciónRESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: Chinese herbal preparation of Liu-He-Dan ointment has been adapted for acute pancreatitis in external application for many years in West China. AIM OF THE STUDY: To investigate the effect of acute pancreatitis on the pharmacokinetics of Liu-He-Dan ointment in rats while it was used externally on belly. MATERIALS AND METHODS: Twelve male Sprague-Dawley rats were randomly divided into acute pancreatitis model group (n=6) and normal group as a control (n=6). Chinese herbal Liu-He-Dan ointment was used externally on belly. Emodin, rhein, aloe emodin, physcion and chrysophanol in plasma and pancreas (at 48 h) were detected and quantified by liquid chromatography-tandem mass spectrometry. Amylase in plasma were determined with iodide process. RESULTS: Among the five components, only emodin, aloe emodin and physcion from Liu-He-Dan were detected in plasma and pancreas. The absorption of each component was tended to decrease in acute pancreatitis group after topically management with Liu-He-Dan ointment on rats' abdomen. The T(max), C(max) and area under curve (AUC) of each component were distinctly lower in AP group than those in normal group (p<0.05). However, the T(1/2α) and mean retention time (MRT) of emodin lasted longer in acute pancreatitis group than those in normal group (p<0.05). There was no statistical difference in the MRT of aloe emodin and physcion between the two groups. Emodin could be detected in all rats' pancreas at 48 h in both groups, while its mean pancreatic concentration was higher in acute pancreatitis model group than in normal group (0.91 ± 0.68, 0.41 ± 0.36, respectively). Physcion could be detected in pancreas of most acute pancreatitis models, but not in normal rats. Aloe emodin was found in all pancreas from acute pancreatitis models while only one in normal group. The level of amylase in Liu-He-Dan group was obviously lower than that in the AP model group (p=0.0055). CONCLUSION: We concluded that acute pancreatitis may significantly affect the pharmacokinetics of Liu-He-Dan while external applied on belly, which indicated the dosage modification in AP. However, acute pancreatitis seems to promote the distribution of the detected components into pancreas. The ointment could help relieve the disease of pancreatitis.
Asunto(s)
Medicamentos Herbarios Chinos/farmacocinética , Pomadas/farmacocinética , Pancreatitis/metabolismo , Administración Cutánea , Amilasas/metabolismo , Animales , Antraquinonas/farmacocinética , Arginina , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/administración & dosificación , Medicamentos Herbarios Chinos/farmacología , Emodina/análogos & derivados , Emodina/farmacocinética , Masculino , Pomadas/administración & dosificación , Páncreas/efectos de los fármacos , Páncreas/metabolismo , Pancreatitis/inducido químicamente , Ratas , Ratas Sprague-DawleyRESUMEN
BACKGROUND: Topical photodynamic therapy (PDT) mediated with 5-aminolevulinic acid (ALA) offers an alternative option for the treatment of acne vulgaris. OBJECTIVE: To study the effects of ALA dose, incubation time, and lesion type on protoporphyrin IX (PpIX) production and treatment outcomes. METHODS: To examine the time course of PpIX production, 10% ALA was applied to inflammatory papules for 1 to 5 hours and followed by in situ fluorescence examination. To determine the effects of ALA dose and lesion type, 3, 5, and 10% ALA was applied to acne lesions in split-face fashion for 3 hours followed by whole-face light irradiation at 633 nm and 30 to 70 J/cm2. Treatment was repeated twice at 2-week intervals. RESULTS: PpIX reached a stable level after 3 hours of incubation. Similar PpIX levels were seen in areas receiving 3, 5, and 10% ALA. Poisson regression analyses indicated that lesion counts decreased by 0.791 times for a one-unit increase in treatment times (95% CI 0.782-0.799 < .0001) but only by 0.999 times for a one-unit increase in ALA dose (95% CI 0.998-1.000 â=â .22). CONCLUSION: The combination of low-dose ALA and a red light is a safe and effective option for the treatment of moderate to severe acne.
Asunto(s)
Acné Vulgar/tratamiento farmacológico , Ácido Aminolevulínico/administración & dosificación , Fotoquimioterapia/métodos , Acné Vulgar/diagnóstico , Acné Vulgar/epidemiología , Administración Tópica , Adulto , Ácido Aminolevulínico/farmacocinética , Relación Dosis-Respuesta a Droga , Femenino , Estudios de Seguimiento , Humanos , Masculino , Pomadas/administración & dosificación , Pomadas/farmacocinética , Fármacos Fotosensibilizantes/administración & dosificación , Fármacos Fotosensibilizantes/farmacocinética , Estudios Prospectivos , Índice de Severidad de la Enfermedad , Piel/metabolismo , Piel/patología , Resultado del Tratamiento , Adulto JovenRESUMEN
Characterization and release profiles of commercial dexamethasone dipropionate (DDP) from an innovator and 2 generic ointments (Methaderm (IM), Promethasone (GP), and Mainvate (GM)) and their admixtures with heparinoid ointment (Hirudoid Soft) were investigated. The admixtures were prepared using 2 mixing methods (slab or rotation/revolution mixer). Microscopic and FT-Raman spectrometric analyses revealed that the ointments, except for IM, contained DDP crystals. A silicone membrane was used for the evaluation of the DDP permeation. The permeated DDP amounts from GP and GM were lower than that from IM, indicating that DDP solubility in the ointment vehicle affected the release of DDP from the ointment. No significant differences were observed in DDP release between IM alone and its admixture prepared using a slab; however, DDP release from the admixture prepared using a rotation/revolution mixer was significantly lower than those from IM alone and its admixture by slab. In the GP system, DDP release from the admixtures by the 2 mixing methods was higher than that from GP alone, whereas no significant difference in DDP release between the 2 mixing methods was observed. No significant differences were observed between the GM and admixtures. The apparent solubility of DDP in the admixtures as determined by the ultracentrifugal separation method indicated that the DDP amount in the liquid phase of admixtures with GP was 6 times higher than that of admixtures with IM or GM. Therefore, the apparent solubility of DDP in the liquid phase in the GP system might influence the DDP release in admixtures.
Asunto(s)
Preparaciones de Acción Retardada , Dexametasona/análogos & derivados , Excipientes/química , Heparinoides/química , Pomadas/química , Esteroides/química , Antiinflamatorios/química , Antiinflamatorios/farmacocinética , Química Farmacéutica , Preparaciones de Acción Retardada/farmacocinética , Dexametasona/química , Dexametasona/farmacocinética , Heparinoides/farmacocinética , Pomadas/farmacocinética , Solubilidad , Espectrometría RamanRESUMEN
OBJECTIVE: Through the comparison of Xiaoyu ointment and xiaoyu plaster by in vitro transdermal demonstrate, to demonstrate the scientificity and feasibility of reformed formulation. METHOD: The improved Franz diffusion cells and in vitro rabbit skin were used in vitro penetration experiment with emodin as an indicator of penetration rate quantitated by HPLC. RESULT: The cumulative penetration rate of emodin in Xiaoyu ointment fit the model of Weibull distribution, while the cumulative penetration rate of emodin in Xiaoyu plaster fit the model of Density equation. Take emodin as an index,the transdermal rate in Xiaoyu plaster was 1.93 times as Xiaoyu ointment, and the total penetrated amount was 2.84 times as Xiaoyu ointment. The results showed that the emodin of xiaoyu plaster reserved in the skin were 3.95 times more than the ointment. CONCLUSION: The penetration rate, total penetrated amount and the reserves in the skin of Xiaoyu plaster were better than the ointment, and the transdermal dosage form was better than the original form.
Asunto(s)
Pomadas/farmacocinética , Piel/metabolismo , Administración Cutánea , Animales , Cromatografía Líquida de Alta Presión , Conejos , Absorción CutáneaRESUMEN
Skin cream is commonly used to improve skin health and create a smooth, soft and moist perception by altering the surface roughness, friction, adhesion, elasticity and surface charging of skin surface. In this study, we present the first systematic study on friction, adhesion, durability and influence of humidity on adhesion and surface charging of skin and various skin creams using atomic force microscopy. Skin is subjected to various daily activities with time, and the durability is closely tied to product compositions. Durability of various skin creams was studied by repeated cycling tests. In order to better understand the frictional behaviour, the dynamic viscosities of various skin creams were measured. Skin cream thinly coats the skin surface and can cause drastic changes in the mechanical properties. In addition to mechanical properties, adhesive force is one of the important factors in determining the tactile perception of skin cream and is directly affected by the film thickness. Because the environmental dependence of skin and skin cream is of importance, the influence of humidity on adhesive force, film thickness and Young's modulus mapping were measured using force distance technique. The health and feel of skin are significantly affected by its surface charging, the surface potential of skin and various cream-treated skins was measured using the Kelvin probe method.
Asunto(s)
Estabilidad de Medicamentos , Pomadas/administración & dosificación , Pomadas/farmacocinética , Piel , Animales , Fricción , Humedad , Microscopía de Fuerza Atómica , Ratas , PorcinosRESUMEN
Monitoring the physiological effects of biological mediators on vascular permeability is important for identifying potential targets for antivascular leak therapy. This therapy is relevant to treatments for pulmonary edema and other disorders. Current methods of quantifying vascular leak are in vitro and do not allow repeated measurement of the same animal. Using an in vivo diffuse reflectance optical method allows pharmacokinetic analysis of candidate antileak molecules. Here, vascular leak is assessed in mice and rats by using the Miles assay and introducing irritation both topically using mustard oil and intradermally using vascular endothelial growth factor (VEGF). The severity of the leak is assessed using broadband diffuse reflectance spectroscopy with a fiber reflectance probe. Postprocessing techniques are applied to extract an artificial quantitative metric of leak from reflectance spectra at vascular leak sites on the skin of the animal. This leak metric is calculated with respect to elapsed time from irritation in both mustard oil and VEGF treatments on mice and VEGF treatments on rats, showing a repeatable increase in leak metric with leak severity. Furthermore, effects of pressure on the leak metric are observed to have minimal effect on the reflectance spectra, while spatial positioning showed spatially nonuniform leak sites.
Asunto(s)
Pomadas/administración & dosificación , Pomadas/farmacocinética , Fotometría/métodos , Absorción Cutánea/fisiología , Piel/metabolismo , Análisis Espectral/métodos , Administración Tópica , Animales , Ratones , Ratones Endogámicos BALB C , Ratas , Ratas Endogámicas F344RESUMEN
The purpose of this study was to evaluate the potential irritating effects and the systemic exposure level of an antibacterial ointment containing REP8839 as a single agent or in combination with mupirocin versus Bactroban Nasal in rabbits. Additionally, the reversibility of REP8839 effects during a 14-day recovery period was assessed. Five treatment groups of six male and six female New Zealand White rabbits received dose levels of 1%, 2%, and 4% REP8839, 2% Bactroban Nasal, or 2% REP8839/2% mupirocin combination. One additional group of six animals/sex served as the control and received the vehicle, Petrolatum/Softisan 649. The test article or vehicle was administered to all groups via topical administration to the external nares, twice a day (approx. 8h intervals between the doses) for 21 consecutive days, at a dose volume of 100 microL per nare/dose for a total of 400 microL per day (200 microL per nare). Two animals/sex/group were maintained for a 14-day recovery period. The external nares were reflected back and the mucosal lining was evaluated and scored for erythema and edema within 30-60 min following the first dose each day. Blood samples were collected from all animals at designated time points on Day 21 of the study to assess systemic exposure levels. Cross-sectioning of the nasal tract was conducted in all the groups for microscopic evaluation. Mucosal scoring of the nares did not reveal any edema or erythema in any of the dose groups with the antibacterial alone, with the combination product, or with Bactroban Nasal. Mean body weights and food consumption were not adversely impacted by the test articles. Minimal plasma exposure was observed in the rabbits (<5 ng/mL). The REP8839 groups did appear to have dose-responsive exposure (from below the limit of quantitation to 5 ng/mL with 1%, 2%, and 4% REP8839, respectively). Microscopic changes on the nasal sectioning noted in these animals were infrequent and considered incidental findings unrelated to administration of the test articles. In conclusion doses of up to 4% of REP8839 ointment as a single agent or 2% in the combination product, as well as 2% Bactroban Nasal, were not found to induce mucosal irritation when applied topically to the external nares twice a day for 21 consecutive days. Additionally, no delayed effects were observed in the recovery animals.
Asunto(s)
Antibacterianos/efectos adversos , Diaminas/efectos adversos , Irritantes/efectos adversos , Mucosa Nasal/efectos de los fármacos , Tiofenos/efectos adversos , Administración Intranasal , Animales , Antibacterianos/administración & dosificación , Antibacterianos/sangre , Disponibilidad Biológica , Diaminas/administración & dosificación , Diaminas/sangre , Diaminas/farmacocinética , Relación Dosis-Respuesta a Droga , Combinación de Medicamentos , Edema/inducido químicamente , Eritema/inducido químicamente , Femenino , Irritantes/administración & dosificación , Irritantes/farmacocinética , Masculino , Mupirocina/administración & dosificación , Mupirocina/efectos adversos , Mupirocina/sangre , Mupirocina/farmacocinética , Mucosa Nasal/patología , Nariz , Pomadas/efectos adversos , Pomadas/farmacocinética , Conejos , Tiofenos/administración & dosificación , Tiofenos/sangre , Tiofenos/farmacocinéticaRESUMEN
OBJECTIVES: We studied the uptake of polycyclic aromatic hydrocarbons (PAH) in nurses who apply ointments containing coal tar to patients and investigated the effectiveness of skin protection methods. METHODS: We determined gas-phase PAH on XAD-2 and particle-associated PAH on filters. We also used pads to determine PAH on the skin. Pyrene and benzo(a)pyrene were analyzed by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry; their respective urinary metabolites 1-hydroxypyrene and 3-hydroxybenzo(a)pyrene were analyzed using high performance liquid chromatography with fluorescence detection. RESULTS: We ruled out the inhalation of airborne pyrene and benzo(a)pyrene as the sources of PAH exposure. However, substantial amounts of pyrene and benzo(a)pyrene were observed on the hands of the nurses (median 33.0 and 16.4 ng/cm (2), respectively). Excretion of urinary 1-hydroxypyrene indicated an increased uptake of pyrene in 8 out of 12 nurses. We asked 35 nurses to perform a treatment with gloves followed by a second treatment without gloves. The use of gloves changed the excretion of 1-hydroxypyrene by -0.58 mumol (range -5.1-1.0 mumol), corresponding to a median reduction of 51.5% (P<0.001). Based on this finding, a new protocol was adopted, involving the permanent use of vinyl gloves and Tyvek sleeves. The effectiveness of this protocol was tested against pre-existing work practices and showed a 97% reduction in skin contamination with pyrene and benzo(a)pyrene, and a lowering in urinary excretion of 1-hydroxypyrene of 57%. CONCLUSION: Protecting the skin more stringently reduced pyrene and benzo(a)pyrene contamination of the hands, and lowered urinary excretion of 1-hydroxypyrene.
Asunto(s)
Guantes Protectores , Enfermeras y Enfermeros , Exposición Profesional/prevención & control , Hidrocarburos Policíclicos Aromáticos/farmacocinética , Hidrocarburos Policíclicos Aromáticos/envenenamiento , Adulto , Alquitrán/farmacocinética , Alquitrán/envenenamiento , Monitoreo del Ambiente , Humanos , Persona de Mediana Edad , Exposición Profesional/efectos adversos , Pomadas/farmacocinética , Pirenos/metabolismo , Piel/metabolismo , Absorción Cutánea , Enfermedades de la Piel/enfermería , Encuestas y CuestionariosRESUMEN
The objective was to quantify acyclovir (ACV) exposure in the dermis following iontophoresis of nontraditional (pH-11 gels) and traditional (neutral cream) topical formulations of ACV. Given that the application time of a formulation on the skin can be significantly reduced with iontophoresis, the use of formulations optimized for iontophoretic delivery was explored to maximize the delivery of ACV to the site of action for the treatment of Herpes-labialis. Microdialysis probes were inserted into the shaved skin of tranquilized rabbits. Iontophoresis was performed at a constant current density of 200 microA/cm(2) for 60 min using a single-use drug cartridge filled with the following formulations: neutral cream, soluble fraction of the same cream (anodal and cathodal-current), or two formulations of pH-11 gels, one without and one with stabilizers and preservatives (cathodal-current). Results showed that only the ACV in the water phase of the cream is available for transport. All of the pH-11 gels exhibited a statistically significant (p < 0.001) increase in ACV dermis exposure compared to the neutral cream formulations without any additional sign of skin irritation. In conclusion, iontophoresis of ACV pH-11 gels provides higher ACV concentrations in the dermis than iontophoresis of neutral cream formulations, which could result in a better clinical outcome.
Asunto(s)
Aciclovir/administración & dosificación , Antivirales/administración & dosificación , Pomadas/administración & dosificación , Pomadas/química , Piel/metabolismo , Aciclovir/farmacocinética , Animales , Antivirales/farmacocinética , Femenino , Concentración de Iones de Hidrógeno , Iontoforesis/métodos , Microdiálisis , Pomadas/farmacocinética , ConejosRESUMEN
BACKGROUND: The pharmaceutical market offers a wide range of inhalant drug products applied on the skin that contain essential oils and/or their isolated compounds, i.e. terpenes. Because there are few data concerning the skin penetration of terpenes, especially from complex carriers, the goal of this study was to determine the ex vivo skin absorption kinetics of chosen terpenes, namely eucalyptol, menthol, camphor, alpha-pinene, and beta-pinene, from the product Vicks VapoRub. MATERIAL/METHODS: Human cadaver skin was placed in a flow-through diffusion chamber and the product was applied for 15, 30, and 60 min. After the application time the skin was separated into layers using a tape-stripping technique: three fractions of stratum corneum and epidermis with dermis, and terpenes amounts in the samples were determined by gas-chromatography. RESULTS: The investigated terpenes showed different absorption characteristics related to their physicochemical properties and did not permeate through the skin into the acceptor fluid. Eucalyptol had the largest total accumulation in the stratum corneum and in the epidermis with dermis, while alpha-pinene penetrated into the skin in the smallest amount. CONCLUSIONS: The short time in which saturation of the stratum corneum with the terpenes occurred and the high accumulation of most of the investigated terpenes in the skin layers proved that these compounds easily penetrate and permeate the stratum corneum and that in vivo they may easily penetrate into the blood circulation.
Asunto(s)
Pomadas/metabolismo , Extractos Vegetales/metabolismo , Absorción Cutánea , Terpenos/metabolismo , Adulto , Monoterpenos Bicíclicos , Compuestos Bicíclicos con Puentes/química , Compuestos Bicíclicos con Puentes/metabolismo , Cadáver , Alcanfor/química , Alcanfor/metabolismo , Ciclohexanoles/química , Ciclohexanoles/metabolismo , Combinación de Medicamentos , Eucaliptol , Femenino , Humanos , Técnicas In Vitro , Mentol/química , Mentol/metabolismo , Persona de Mediana Edad , Monoterpenos/química , Monoterpenos/metabolismo , Pomadas/química , Pomadas/farmacocinética , Extractos Vegetales/química , Extractos Vegetales/farmacocinética , Terpenos/química , Terpenos/farmacocinéticaRESUMEN
BACKGROUND: Cytokines play a pivotal role in allergy development through activating signaling mechanisms, such as the Janus kinase/signal transducer and activator of transcription (STAT) pathway, which controls the expression of numerous proinflammatory genes. OBJECTIVE: In comparison with 2 different corticosteroids and a calcineurin inhibitor, the efficacy of a STAT1 decoy oligodeoxynucleotide (dODN)-containing ointment on hapten-induced contact hypersensitivity was examined in 3 different animal models. METHODS: After sensitization, the test compounds were administered before hapten challenge, after hapten challenge, or both to different sites of the animal skin. Subsequent erythema and edema formation was scored macroscopically, microscopically, or by a shift in ear weight. Biopsy specimens were taken and processed for histopathology, immunohistochemistry, and real-time PCR analyses. RESULTS: Treatment with the STAT1 dODN but not the corresponding control ODN markedly improved the clinical signs of inflammation in all 3 animal models in a dose-related manner. In guinea pig skin this was accompanied by a distinct decrease in leukocyte infiltration into the dermis after 24 hours. In addition, expression of CD40, IFN-gamma, IL-1beta, IL-8, IL-12, and TNF-alpha was strongly attenuated. The dODN was equally effective in the domestic pig model when administered therapeutically, and its preventive effect in the mouse model lasted for more than 48 hours. CONCLUSIONS: Altogether, treatment with the dODN proved to be at least as effective as treatment with the reference compounds.